Guide
Healthcare Technology Marketing in 2026
Health tech in 2026 is fast-growing but unforgiving: funding and AI adoption are surging, yet growth is gated by long multi-stakeholder sales cycles, strict HIPAA constraints on the very martech marketers rely on, and rising demands for clinical evidence. This guide covers the market, the compliance reality (why Meta, Google, and LinkedIn won't sign BAAs), and how to sell to committees of providers, payers, and patients.
Healthcare Technology Marketing in 2026
Health tech is one of the most exciting and most constrained markets a growth marketer can work in. The opportunity is enormous — Grand View Research projects the global digital health market reaching roughly $1.8 trillion by 2033, growing about 23% a year — and capital is flowing again: US digital health venture funding hit $14.2 billion in 2025, up 35% over 2024. But the constraints are unlike anything in consumer or standard B2B.
AI is reshaping the buyer
Adoption has moved fast. Physician use of health AI nearly doubled to 66% in 2024, from 38% the year before, and half of 2025 digital health deals were AI-enabled, capturing 54% of total funding. That's reshaping buying behavior in different directions depending on who's buying: Menlo Ventures found AI buying cycles compressing for providers — health systems went from 8.0 to 6.6 months — even as payer cycles lengthened to 11.3 months.
The compliance reality: HIPAA breaks your martech
This is the part that blindsides marketers coming from other industries. Standard digital marketing infrastructure often can't be used as-is with protected health information. HIPAA requires written authorization before PHI is used for most marketing, and major ad and analytics platforms — Meta, Google Ads, LinkedIn Ads, GA4 — won't sign Business Associate Agreements. The enforcement is real: HHS and the FTC warned roughly 130 hospital systems and telehealth providers about online tracking technologies like the Meta Pixel and Google Analytics.
Practically, that means retargeting, pixel-based conversion tracking, and lookalike audiences built on patient data are often off the table without authorization, BAAs, or privacy-first alternatives. Your measurement and martech stack has to be designed for compliance from the start — a first-party, consent-based foundation, as in our first-party and zero-party data guide, rather than the third-party tracking most growth playbooks assume.
Selling to committees — and to trust
Health-tech purchases are multi-stakeholder by nature, pulling in clinical, IT, finance, and compliance, each conducting independent research. And the bar is evidence: payers and health systems increasingly demand clinical proof and outcomes data, not marketing claims. Patient-facing trust is fragile, too — a 2026 KFF poll found 77% of adults are concerned about the privacy of medical information given to AI tools, even as 32% have used AI for health information.
The 2026 health-tech playbook
- Lead with evidence. Clinical studies, outcomes data, and credible third-party validation are the currency. Build the content library around proof.
- Design a compliant stack first. Assume your default ad and analytics tools need BAAs or privacy-first replacements; bake consent and first-party data into the foundation.
- Map the full committee. Provider, payer, and patient audiences want different things — clinical efficacy, ROI and reimbursement, safety and privacy — and your content has to serve each.
- Earn organic and AI visibility. With paid targeting constrained, owned content and AI search visibility carry more weight — and patients increasingly ask AI tools health questions, making accurate, authoritative presence essential.
Running compliant, evidence-led growth for healthcare technology companies — across a revenue engine built for long institutional cycles and an SEO/AI-search program that respects privacy — is exactly what our sales revenue engine and SEO & AI search teams do.
Sources
- https://www.grandviewresearch.com/press-release/global-digital-health-market
- https://rockhealth.com/insights/2025-year-end-digital-health-funding-overview-a-tale-of-two-markets/
- https://www.ama-assn.org/practice-management/digital-health/2-3-physicians-are-using-health-ai-78-2023
- https://menlovc.com/perspective/2025-the-state-of-ai-in-healthcare/
- https://www.hipaajournal.com/hipaa-marketing-rules/
- https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/hipaa-online-tracking/index.html
- https://www.kff.org/public-opinion/kff-tracking-poll-on-health-information-and-trust-use-of-ai-for-health-information-and-advice/
Related services
FAQ
Quick
answers.
Purchases involve six to ten stakeholders plus security reviews and BAAs, but Menlo Ventures found AI buying cycles compressing for providers (health systems 8.0 to 6.6 months) even as payer cycles lengthened to 11.3 months — so it depends on buyer type.
Keep reading
Go deeper.
Your growth starts here
Let's build the
growth engine.
Tell us where growth is stuck. We'll show you what one integrated team can move — and how fast.